JP2022523212A5 - - Google Patents
Info
- Publication number
- JP2022523212A5 JP2022523212A5 JP2021549801A JP2021549801A JP2022523212A5 JP 2022523212 A5 JP2022523212 A5 JP 2022523212A5 JP 2021549801 A JP2021549801 A JP 2021549801A JP 2021549801 A JP2021549801 A JP 2021549801A JP 2022523212 A5 JP2022523212 A5 JP 2022523212A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- acceptable salt
- hydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811456P | 2019-02-27 | 2019-02-27 | |
| US62/811,456 | 2019-02-27 | ||
| PCT/US2020/019724 WO2020176527A1 (en) | 2019-02-27 | 2020-02-25 | Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523212A JP2022523212A (ja) | 2022-04-21 |
| JP2022523212A5 true JP2022523212A5 (https=) | 2023-02-24 |
| JP7581219B2 JP7581219B2 (ja) | 2024-11-12 |
Family
ID=70005768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549801A Active JP7581219B2 (ja) | 2019-02-27 | 2020-02-25 | ニューモシスチス属種（Ｐｎｅｕｍｏｃｙｓｔｉｓ ｓｐｐ．）肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12594266B2 (https=) |
| EP (1) | EP3930716B1 (https=) |
| JP (1) | JP7581219B2 (https=) |
| KR (1) | KR20210133241A (https=) |
| CN (1) | CN113631165A (https=) |
| AU (1) | AU2020228036B2 (https=) |
| BR (1) | BR112021016876A2 (https=) |
| CA (1) | CA3131298A1 (https=) |
| EA (1) | EA202192344A1 (https=) |
| ES (1) | ES3055272T3 (https=) |
| IL (1) | IL285839A (https=) |
| MA (1) | MA55081A (https=) |
| MX (2) | MX2021010311A (https=) |
| TW (1) | TWI910099B (https=) |
| WO (1) | WO2020176527A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK173802B1 (da) * | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
| US5166135A (en) * | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| DK2007396T3 (da) | 2006-04-03 | 2013-03-18 | Merck Sharp & Dohme | Enfumafungin-derivat som antimykotika |
| US8188085B2 (en) | 2008-08-12 | 2012-05-29 | Merck Sharp & Dohme Corp. | Antifungal agents |
| CN108883152A (zh) * | 2016-01-08 | 2018-11-23 | 奇达拉治疗公司 | 防止和治疗肺孢子虫感染的方法 |
| EP3609539A1 (en) * | 2017-04-10 | 2020-02-19 | Scynexis, Inc. | Antifungal agents used in combination |
| EP4732902A2 (en) * | 2017-08-04 | 2026-04-29 | Scynexis, Inc. | Antifungal agents with enhanced activity in acidic ph |
-
2020
- 2020-02-25 MA MA055081A patent/MA55081A/fr unknown
- 2020-02-25 MX MX2021010311A patent/MX2021010311A/es unknown
- 2020-02-25 US US17/432,926 patent/US12594266B2/en active Active
- 2020-02-25 ES ES20714386T patent/ES3055272T3/es active Active
- 2020-02-25 WO PCT/US2020/019724 patent/WO2020176527A1/en not_active Ceased
- 2020-02-25 BR BR112021016876A patent/BR112021016876A2/pt unknown
- 2020-02-25 CA CA3131298A patent/CA3131298A1/en active Pending
- 2020-02-25 AU AU2020228036A patent/AU2020228036B2/en active Active
- 2020-02-25 CN CN202080023125.XA patent/CN113631165A/zh active Pending
- 2020-02-25 EA EA202192344A patent/EA202192344A1/ru unknown
- 2020-02-25 EP EP20714386.8A patent/EP3930716B1/en active Active
- 2020-02-25 KR KR1020217030157A patent/KR20210133241A/ko active Pending
- 2020-02-25 JP JP2021549801A patent/JP7581219B2/ja active Active
- 2020-02-27 TW TW109106501A patent/TWI910099B/zh active
-
2021
- 2021-08-24 IL IL285839A patent/IL285839A/en unknown
- 2021-08-26 MX MX2025004197A patent/MX2025004197A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5744976B2 (ja) | にきびの治療方法発明の分野 | |
| JP2010532372A5 (https=) | ||
| US20080161369A1 (en) | Epothilone derivative for the treatment of hepatoma and other cancer diseases | |
| CN102046180A (zh) | 用于免疫治疗的组合物和方法 | |
| TWI441639B (zh) | 用於治療卵巢癌之包含紫杉醇之組合 | |
| WO2005034936A1 (en) | Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct | |
| CN103327975A (zh) | 用于治疗多形性成胶质母细胞瘤的含有马西替坦的组合物 | |
| JP2023553253A5 (https=) | ||
| JP2023548429A5 (https=) | ||
| JP2020529999A5 (https=) | ||
| JP2025517509A5 (https=) | ||
| JP2022523212A5 (https=) | ||
| JP7357386B2 (ja) | 化合物又はその薬学的に許容される塩、二量体又は三量体のがん治療用医薬品の調製における応用 | |
| JP2020529999A (ja) | 酸性ｐＨで活性の増強を示す抗真菌剤 | |
| JP2023531930A5 (https=) | ||
| JP2024527715A5 (https=) | ||
| RU2195937C1 (ru) | Комбинированный противотуберкулезный препарат (ризобутол) | |
| JP2022519500A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| JP2020536092A (ja) | 細菌感染症の治療方法 | |
| JP2024545293A5 (https=) | ||
| JP2022532734A5 (https=) | ||
| EP1465607A1 (fr) | Compositions pharmaceutiques a liberation modifiee | |
| JP2018177773A (ja) | 医薬 | |
| TW200950789A (en) | Antitumor agent, kit and method of treating cancer |